Long-term oncologic outcomes after neoadjuvant radiation therapy for retroperitoneal sarcomas

Annals of Surgery

Volumn 262, Issue 1, 2015, Pages 163-170

  Nussbaum, Daniel P ^a   Speicher, Paul J ^a   Gulack, Brian C ^a   Ganapathi, Asvin M ^a   Englum, Brian R ^a   Kirsch, David G ^b   Tyler, Douglas S ^a   Blazer, Dan G ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neoadjuvant; Preoperative; Radiation therapy; Radiotherapy; Retroperitoneal sarcoma; Sarcoma

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; FEMALE; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROPERITONEAL SARCOMA; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; ADJUVANT RADIOTHERAPY; MIDDLE AGED; NEOADJUVANT THERAPY; RETROPERITONEAL NEOPLASMS; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84942522804     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000840     Document Type: Article

References (27)

1. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355-365.
2. Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31:1649-1655.
3. Caudle AS, Tepper JE, Calvo BF, et al. Complications associated with neoad-juvant radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas. Ann Surg Oncol. 2007;14:577-582.
4. Tzeng CW, Fiveash JB, Popple RA, et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer. 2006;107:371-379.
5. Pawlik TM, Ahuja N, Herman JM. The role of radiation in retroperitoneal sarcomas: a surgical perspective. Curr Opin Oncol. 2007;19:359-366.
6. Zlotecki RA, Katz TS, Morris CG, et al. Adjuvant radiation therapy for re-sectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol. 2005;28:310-316.
7. Pawlik TM, Pisters PW, Mikula L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate-or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006;13: 508-517.
8. McBride SM, Raut CP, Lapidus M, et al. Locoregional recurrence after preop-erative radiation therapy for retroperitoneal sarcoma: adverse impact of mul-tifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013;20:2140-2147.
9. Brennan MF. Lessons learned from the study of soft tissue sarcoma. Int J Surg. 2013;11(suppl 1):S8-S10.
10. Bonvalot S, Litiere S, Nzokirantevye A, et al. A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcomas In: http://www.eortc.org/[Internet]. Brussels, Belgium: European Organisation for Research and Treatment of Cancer. Available at http://www.eortc.be/protoc/details.asp?protocol=62092. Accessed May 1, 2014.
11. National Cancer Data Base. American College of Surgeons: cancer programs: National Cancer Data Base (NCDB). Available at http://www.facs.org/cancer/ncdb/. Published 2013.
12. National Cancer Data Base. National Cancer Data Base-Data Dictionary. Chicago, IL: NCDB (American College of Surgeons Commission on Cancer); 2013. Available at: http://ncdbpuf.facs.org/?q=node/259. Accessed May 1, 2014.
13. Zagar TM, Shenk RR, Kim JA, et al. Radiation therapy in addition to gross total resection of retroperitoneal sarcoma results in prolonged survival: results from a single institutional study. J Oncol. 2008;2008:824036.
14. White JS, Biberdorf D, DiFrancesco LM, et al. Use of tissue expanders and pre-operative external beam radiotherapy in the treatment of retroperitoneal sarcoma. Ann Surg Oncol. 2007;14:583-590.
15. Sargos P, Dejean C, de Figueiredo BH, et al. High-dose pre-operative helical tomotherapy (54 Gy) for retroperitoneal liposarcoma. Radiat Oncol. 2012;7: 214.
16. Roeder F, Schulz-Ertner D, Nikoghosyan AV, et al. A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperi-toneal soft tissue sarcoma. BMC Cancer. 2012;12:287.
17. Alford S, Choong P, Chander S, et al. Outcomes of preoperative radiotherapy and resection of retroperitoneal sarcoma. ANZ J Surg. 2013;83:336-341.
18. El-Bared N, Taussky D, Mehiri S, et al. Preoperative intensity modulated radiation therapy for retroperitoneal sarcoma. Technol Cancer Res Treat. 2013;13:211-216.
19. Smith MJ, Ridgway PF, Catton CN, et al. Combined management of retroperi-toneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. Radiother Oncol. 2014;110:165-171.
20. Yoon SS, Duda DG, Karl DL, et al. Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2011;81:1081-1090.
21. Gronchi A, De Paoli A, Dani C, et al. Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group. Eur J Cancer. 2014;50:784-792.
22. Nussbaum D, Speicher P, Gulack B, et al. The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas. Surg Oncol. In Press.
23. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359-368.
24. Le Pechoux C, Musat E, Baey C, et al. Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma? Ann Oncol. 2013;24:832-837.
25. Sampath S, Hitchcock YJ, Shrieve DC, et al. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol. 2010;101:345-350.
26. Bartlett EK, Roses RE, Meise C, et al. Preoperative radiation for retroperitoneal sarcoma is not associated with increased early postoperative morbidity. J Surg Oncol. 2013;24:832-837.
27. Meric F, Milas M, Hunt KK, et al. Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol. 2000;18:3378-3383.